Volume 16 Number 2

This edition looks at valvular disease and heart failure with an examination of mitral valve repair in the MitraSwiss registry; a fuller understanding of the use of CT in patients undergoing TAVI; preprocedural planning for coronary re-access in candidates for TAVI-in-TAVI; a minifocus in Coronary interventions with a series on thin strut scaffolds; and, a look at interventional pharmacology with the SAFE-A trial comparing DAPT durations in patients with atrial fibrillation on apixaban requiring coronary stenting.

In this issue of EuroIntervention

Mitral valve repair, TAVI planning, valve-in-valve and coronary re-access, clinical and experimental outcomes of thin-strut coronary scaffolds, short DAPT in patients on apixaban, and more

Capodanno D

free

Interventions for valvular disease and heart failure

Impact of mitral regurgitation aetiology on MitraClip outcomes: the MitraSwiss registry

Sürder D, Klersy C, Corti R, Biasco L, Gaemperli O, Maisano F, Toggweiler S, Jeger RV, Naegeli B, Noble S, Biaggi P, Moccetti T, Pedrazzini G

10.4244/EIJ-D-19-00718

free

Editorial comment

Lessons learned from the MitraSwiss registry

Ince H, D’Ancona G

10.4244/EIJV16I2A14

free

Impact of right ventricular volumes on the outcomes of TAVR: a volumetric analysis of preprocedural computed tomography

Rozenbaum Z, Maret E, Lax L, Shmilovich H, Finkelstein A, Steinvil A, Halkin A, Banai S, Cohen D, Topilski Y, Berliner S, Fleischmann D, Aviram G

10.4244/EIJ-D-19-00651

free

TAVR-in-TAVR and coronary access: importance of preprocedural planning

Tarantini G, Fabris T, Nai Fovino L

10.4244/EIJ-D-19-01094

free

Editorial comment

TAV-in-TAV for failed prosthesis: the new frontier

Tchétché D, Siddiqui S

10.4244/EIJV16I2A15

free

Coronary interventions

First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial

Chieffo A, Khawaja S, Latib A, Vesga B, Moncada M, Delgado J, Fonseca J, Testa L, Esposito G, Ferrone M, Cortese B, Maehara A, Granada JF, Colombo A

10.4244/EIJ-D-19-00600

free

Editorial comment

Bioresorbable scaffolds: did we jump the gun?

Waksman R, Forrestal B

10.4244/EIJV16I2A16

free

Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.

Katagiri Y, Torii R, Takahashi K, Tenekecioglu E, Asano T, Chichareon P, Tomaniak M, Piek J, Wykrzykowska JJ, Bullett N, Ahmed N, Al-Lamee R, Leclerc G, Kitslaar P, Dijkstra J, Reiber JH, Poon E, Bourantas C, Gijsen F, Serruys PW, Onuma Y

10.4244/EIJ-D-18-01190

free

Procedural microvascular activation in long lesions treated with bioresorbable vascular scaffolds or everolimus-eluting stents: the PROACTIVE trial

Pellicano M, Di Gioia G, Ciccarelli G, Xaplanteris P, Delrue L, Toth GG, Van Durme F, Heyse A, Wyffels E, Vanderheyden M, Bartunek J, De Bruyne B, Barbato E

10.4244/EIJ-D-18-01138

free

Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial

Gomez-Lara J, Salvatella N, Romaguera R, Brugaletta S, Nato M, Roura G, Ferreiro J, Teruel L, Gracida M, Sabaté M, Vaquerizo B, Cequier A, Gomez-Hospital J

10.4244/EIJ-D-18-01203

free